06.02.2020 Views

In Vitro Diagnostics Market Demand, Scope and Global Competitive Insights 2025

In Vitro Diagnostics Market by Technology (Point of Care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, and Coagulation and Hemostasis), Application (Drug Testing, Infectious Disease, Oncology, Metabolic Disease, and Autoimmune Disease), Geography and Forecast

In Vitro Diagnostics Market by Technology (Point of Care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, and Coagulation and Hemostasis), Application (Drug Testing, Infectious Disease, Oncology, Metabolic Disease, and Autoimmune Disease), Geography and Forecast

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

©2019 Transparency Market Research, All Rights Reserved

In Vitro Diagnostics Market

Technology - Point of Care, Molecular Diagnostics,

Immunoassays, Clinical Chemistry, Whole Blood Glucose

Monitoring, Hematology, Clinical Microbiology, and

Coagulation and Hemostasis; Application - Drug Testing,

Infectious Disease, Oncology, Metabolic Disease, and

Autoimmune Disease; End User - Diagnostics Laboratories,

Hospitals, Academic & Research Centers, and Home Care

Forecast 2017 - 2025

©2019 Transparency Market Research, All Rights Reserved


©2019 Transparency Market Research, All Rights Reserved

Table of Content

Sr. No.

Chapter1

Chapter 2

Chapter 3

Chapter 4

Chapter 5

Chapter 6

Chapter 7

Chapter 8

Chapter 9

Chapter 10

Chapter 11

Chapter 12

Chapter 13

Chapter 14

Chapter 15

Chapter 16

Content

Preface

Assumptions and Acronyms Used

Research Methodology

Executive Summary

Market Overview

Market Dynamics

Global In Vitro Diagnostics Market Analysis By Technology Type

Global In Vitro Diagnostic Market Analysis, by Application

Global In Vitro Diagnostic Market Analysis, by End Users

Global In Vitro Diagnostics Market Analysis, by Region

North America In Vitro Diagnostic Market Analysis

Europe In Vitro Diagnostic Market Analysis

Asia Pacific In Vitro Diagnostic Market Analysis

Latin America In Vitro Diagnostic Market Analysis

Middle East & Africa In Vitro Diagnostic Market Analysis

Company Profiles


©2019 Transparency Market Research, All Rights Reserved

In Vitro Diagnostics Market: Snapshot

• The development of the condition-specific tests and markers and the rise in the adoption

of point-of-care testing are projected to support the growth of the Market.

• A tremendous rise in the geriatric population and the increasing prevalence of infectious

and chronic diseases are estimated to support the growth of the global in vitro

diagnostics market in the next few years.

• By technology type market further segmented into point of care, molecular diagnostics,

immunoassays, clinical chemistry, whole blood glucose monitoring, hematology, clinical

microbiology, coagulation and hemostasis, and others.

©2019 Transparency Market Research, All Rights Reserved


©2019 Transparency Market Research, All Rights Reserved

©2019 Transparency Market Research, All Rights Reserved


©2019 Transparency Market Research, All Rights Reserved

Reports Highlights

• Global market for in vitro diagnostics was worth US$55000 mn and is projected to reach

a value of US$89862.2 mn by the end of 2025. The market is projected to register a

healthy 5.60% CAGR between 2017 and 2025

• The key findings section included in the report would assist existing market players in

expanding their market shares, and new companies in establishing their presence in the

global In Vitro Diagnostics Market. The key players operating in the in vitro diagnostics

market are Abbott., Becton Dickinson and Company

• Application - Drug Testing, Infectious Disease, Oncology, Metabolic Disease, Autoimmune

Disease, Others

©2019 Transparency Market Research, All

Rights Reserved

Request Sample


©2019 Transparency Market Research, All Rights Reserved

Continue..

• In September, 2017, Amgen Inc. And ALLERGAN Collectively Obtained FDA

Approval For The Use Of MVASI To Treat Five Types Of Cancer.

• Continuous Launch Of New Products And Increase In The Number Of Patients In

Developed And Developing Countries.

• Expansion Of Drugs Delivery System Portfolio: By Improving Existing Drug

Delivery Devices And Developing And Launching Of New Drug Delivery System

Through Collaboration.

©2019 Transparency Market Research, All

Rights Reserved

Request Brochure


©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website:

www.transparencymarketresearch.com

For sales queries or new topics email us on:

sales@transparencymarketresearch.com

For other queries contact:

90 State Street, Albany

NY – 12207, United States

Tel: +1-518-618-1030

T

H

A

N

K

Y

O

U

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!